Drug Approval | January 19, 2024
Zydus and Synthon inks licensing and supply agreement for Palbociclib Tablets for US market
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
Collaboration streamlines patient access to oncology clinical trials
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
Subscribe To Our Newsletter & Stay Updated
